Top 5 Pitfalls in Managing Shock - Medscape
Jul 9, 2019 · The following is a list of top 5 pitfalls in managing shock, based on 25 years of personal experience in clinical care and medical malpractice consultation work.
Dopamine or Norepinephrine for Shock? - Medscape
Jun 28, 2010 · For patients with cardiogenic shock, dopamine seems to result in more arrhythmias than norepinephrine; therefore, norepinephrine should probably be the drug of first choice for …
How to Diagnose and Treat Pruritus in Older Adults - Medscape
Jan 10, 2025 · Neurogenic and Psychogenic Origins Neurogenic pruritus can occur during a stroke, presenting as contralateral pruritus, or in the presence of a brain tumor or following …
IMGs Keep the NHS Running ‘But We Feel Overlooked’ - Medscape
How did the ‘Tackling the NHS Culture Shock’ teaching programme come about? A year after joining the NHS, I reflected on the challenges I faced adapting to a new healthcare system and …
Overlooking Early Cardiogenic Shock Leads to Poor Outcomes
Jul 9, 2025 · When early shock isn’t recognized and treated, it can worsen or lead to death, a hospital-based study shows.
Sepsis: A Ticking Time Bomb - Medscape
Nov 17, 2025 · Dr Husam Issa discusses the rapid nature of sepsis and the importance of intervening early.
Post-COVID Cough Linked to Neurologic Dysfunction - Medscape
Feb 12, 2025 · Recent findings suggest that post-COVID chronic cough may be driven by neurologic factors, not just respiratory issues.
Study Questions ‘One-Size-Fits-All’ Transfusion Approach
Nov 14, 2025 · A trial finds a liberal vs restrictive transfusion threshold for at-risk cardiac patients may improve heart failure and arrhythmia risks, but not major cardiovascular outcomes.
Monoclonal Antibody Shows Promise in Cardiogenic Shock
Jul 24, 2025 · Three critically ill patients treated with procizumab experience a full reversal of cardiogenic shock in 48 hours.
Prehospital Antiplatelet Improves STEMI Vessel Patency
Nov 21, 2025 · A trial of a subcutaneously administered glycoprotein IIb/IIIa inhibitor for ST-elevation myocardial infarction demonstrates improvement in key cardiovascular outcomes.